Vendor, Frederick, MD
Appili Therapeutics USA Inc.
UEI HREVE7N46SM8, CAGE 9D4H9
1 award and $3,605,418 obligated between September 30, 2025 and July 15, 2026, 100% under full and open competition, against 26.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $3,605,418 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93025C00033Definitive Contract, September 30, 2025, Full and Open Competition, 26 offers | National Institutes of Health NiaidNational Institutes of Health | To Advance the Development of the Vaccine Candidate Through Early Clinical Development, Including the Necessary Preparatory Activities and ENAICS 541715, PSC AN11 | $3,605,418 |
- Places of performance
- Maryland
- Product and service codes
- AN11 Health R&D Services; Health Care Services; Basic Research
- Transactions
- 2 across 1 awards